COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q2 2024

Type / Class
Debt / NOTE 2.625% 2/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2024 Q2 $0 $0 -$37,712,983 0
2024 Q1 $26,605,000 $37,712,983 +$811,681 143.0% 7
2023 Q4 $26,039,566 $32,510,998 +$5,639 121.95% 7
2023 Q3 $26,039,566 $26,761,542 +$562 101.5% 7
2023 Q2 $26,039,566 $26,440,939 +$1,014,900 100.79% 7
2023 Q1 $25,019,566 $27,289,994 -$4,005,109,832 107.1% 7
2022 Q4 $128,496,600 $128,197,104 +$1,882,461 101.75% 16
2022 Q3 $130,974,100 $126,245,995 +$2,987,304 86.02% 14
2022 Q2 $129,811,600 $122,917,136 +$78,266 88.13% 14
2022 Q1 $131,944,000 $135,664,199 +$10,037,198 99.74% 14
2021 Q4 $121,963,000 $124,806,000 -$3,671,443 97.51% 13
2021 Q3 $129,026,000 $129,406,102 -$4,815,502 99.85% 16
2021 Q2 $133,276,000 $146,434,836 +$5,994,400 108.86% 17
2021 Q1 $128,105,000 $139,876,013 +$3,002,668 108.92% 16
2020 Q4 $125,635,000 $123,722,398 +$3,816,154 98.93% 17
2020 Q3 $121,703,417 $119,676,395 +$15,937,272 98.8% 19
2020 Q2 $106,265,846 $95,906,878 +$4,664,417 90.17% 20
2020 Q1 $101,019,968 $91,467,945 +$91,467,945 92.0% 19